… at work in two now-deceased participants who were part of early human studies on CERE-120. Autopsies show that four … MJFF is currently funding Ceregene to do just this: Researchers are aiming to find out if neurturin can repair …

… mimic the familial mutations. These mutants all lock LRRK2 into stable structural states that become trapped on … structural dynamics affect their functional role. Impact on Diagnosis/Treatment of Parkinson's Disease: Our structures … into pathogenic states and to provide structures for the research community to design novel types of inhibitors to …

… has traditionally been limited. We aim to reprogram cells into dopaminergic neurons by modifying chromosome structure … are not able to reprogram cells outside of the midbrain into dopaminergic neurons. We hypothesize that this is due … are convertible into dopaminergic neurons. Relevance to Diagnosis/Treatment of Parkinson’s Disease:   One much …

… can extend the reach of clinical studies directly into the home, reducing the burden on research participants, and enabling broader participation in … in future research studies remotely. Relevance to Diagnosis/Treatment of Parkinson’s Disease:                 …

… system to recognize foreign substances, are also used by research scientists to study proteins. Antibodies can be … antibodies that were characterized by a number of PD researchers . MJFF will work with a contract research … widely available to the PD research community. Relevance to Diagnosis/Treatment of Parkinson’s Disease:   A major …

… level, 3D conformations of activated Parkin to gain insight into the mechanism of ubiquitin transfer. Study Design: We … in collaboration with Dr. Gräslund in Sweden. Impact on Diagnosis/Treatment of Parkinson's disease: The structures …